Multiple SclerosisNCT07083856
Effects of Reiki and Self-Acupressure Applications
A study testing Reiki and Self-Acupressure in people with Multiple Sclerosis, run by Firat University at 1 site in Turkey (Türkiye).
Trial summary
Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Read more about this study
- Who is it for?
- Ages 18 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Multiple Sclerosis
- What is being tested?
- Reiki and Self-Acupressure
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 20 Apr 2025to 20 Sep 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Patients who are willing to participate
- Patients who have no communication problems
- Patients who are 18 years of age or older
- Patients who live in the center
- Patients who have no scratches or deformities in the treatment area
- Patients who do not smoke, use drugs, or use tranquilizers, and are not pregnant
- Patients who have been receiving MS treatment for more than three months
Who cannot join
- Patients who smoke, use substances, or use tranquilizers
- Have dyspnea
- Have anemia
- Have diabetes
- Have received corticosteroid treatment in the last three months
- Have had an MS attack in the last three months
Show all 14Show fewer
- Have an autoimmune disease other than multiple sclerosis
- Have signs of infection
- Have a thyroid problem
- Are taking psychostimulant medications
- Have anxiety or depression detected in outpatient clinic screenings
- Refuse to participate in the study
- Have another known neurological system disease (dementia, Alzheimer's, etc.)
- Have a communication barrier will not be included in the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Muğla Sıtkı Koçman University
Muğla, Fethi̇ye, 48300
Furkan Bilek, 05442772249, fzt.furkanbilek@gmail.com
About this study
Official title: Comparison of the Effects of Reiki and Self-Acupressure Applications on Functionality and Quality of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.
- Conditions
- Multiple Sclerosis
- Being tested
- Reiki, Self-Acupressure
- Keywords
- Reiki, Self-Acupressure, Functionality, Quality of Life
- Medical subject headings
- Multiple Sclerosis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ReikiBehavioural
Reiki
Self-AcupressureBehavioural
Self-Acupressure
| Study group | Role | What they receive |
|---|---|---|
| Reiki group | Experimental | Group where Reiki was applied Receives: Behavioral: Reiki |
| Self-acupressure applied group | Experimental | Group where Self-acupressure was applied Receives: Behavioral: Self-Acupressure |
| Control | No intervention | Group with no intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Multiple Sclerosis Quality of Life
The Turkish adaptation of the scale was conducted by Tülek in 2006. Tülek found Cronbach's alpha reliability coefficients to be 0.94 for the composite physical health and 0.89 for the composite mental health. This scale was created by adding 18 items related to MS-specific problems to the items related to general health perception (5 items), energy/fatigue (5 items), social functioning (2 items), emotional well-being (5 items), role limitations due to emotional problems (3 items), physical functioning (10 functions), role limitations due to physical problems (4 items), pain (3 items), and health changes found in the SF-36, a widely used generic quality of life scale for many conditions. The MSQOL-54 Quality of Life Scale consists of two main groups: physical health composite and mental health composite, 13 subgroups, and two independent items. Scores range from 0 to 100, with higher scores indicating higher quality of life.
Measured: 4 weeks
The Multiple Sclerosis Functional Composite
The Scale consists of three subtests: the "9-Hole Peg Test" that evaluates upper extremity functions, the "25-Step Walking Test" that checks lower extremity functions, and the "Step Auditory Serial Addition Test" that evaluates immediate memory and cognitive functions. It was administered within the MSFC.
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2025
- Study start20 Apr 2025
- Primary completion20 Jul 2025 (estimated)
- Study completion20 Sep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Multiple SclerosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Firat University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Furkan BİLEK, Muğla Sıtkı Koçman University
- Investigators
- Caner F Demir, MD, Study chair, Firat University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07083856
- Sponsor's protocol ID
- 2022/ 11- 14
- Status last verified
- Jul 2025
- First submitted
- 17 Jul 2025
- Last updated
- 24 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of the Effects of Reiki and Self-Acupressure Applications on Functionality and Quality of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07083856
- Acronym / sponsor ID
- 2022/ 11- 14
- Conditions
- Multiple Sclerosis
- Keywords
- Reiki, Self-Acupressure, Functionality, Quality of Life
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Firat UniversityUniversity, hospital or other
- Study start
- 20 Apr 2025 (actual)
- Primary completion
- 20 Jul 2025 (estimated)
- Study completion
- 20 Sep 2025 (estimated)
- First posted
- 24 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Reiki group | Experimental | Behavioral: ReikiGroup where Reiki was applied |
| Self-acupressure applied group | Experimental | Behavioral: Self-AcupressureGroup where Self-acupressure was applied |
| Control | No intervention | –Group with no intervention |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Patients who are willing to participate
- Patients who have no communication problems
- Patients who are 18 years of age or older
- Patients who live in the center
- Patients who have no scratches or deformities in the treatment area
Key exclusion criteria (14 listed)
- Patients who smoke, use substances, or use tranquilizers
- Have dyspnea
- Have anemia
- Have diabetes
- Have received corticosteroid treatment in the last three months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ReikiReiki | Behavioural | Reiki group |
| Self-AcupressureSelf-Acupressure | Behavioural | Self-acupressure applied group |
Primary outcome
The Multiple Sclerosis Quality of Life
Time frame: 4 weeks
The Turkish adaptation of the scale was conducted by Tülek in 2006. Tülek found Cronbach's alpha reliability coefficients to be 0.94 for the composite physical health and 0.89 for the composite mental health. This scale was created by adding 18 items related to MS-specific problems to the items related to general health perception (5 items), energy/fatigue (5 items), social functioning (2 items), emotional well-being (5 items), role limitations due to emotional problems (3 items), physical functioning (10 functions), role limitations due to physical problems (4 items), pain (3 items), and health changes found in the SF-36, a widely used generic quality of life scale for many conditions. The MSQOL-54 Quality of Life Scale consists of two main groups: physical health composite and mental health composite, 13 subgroups, and two independent items. Scores range from 0 to 100, with higher scores indicating higher quality of life.
The Multiple Sclerosis Functional Composite
Time frame: 4 weeks
The Scale consists of three subtests: the "9-Hole Peg Test" that evaluates upper extremity functions, the "25-Step Walking Test" that checks lower extremity functions, and the "Step Auditory Serial Addition Test" that evaluates immediate memory and cognitive functions. It was administered within the MSFC.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Multiple Sclerosis
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Multiple Sclerosis
RecruitingPhase 2
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Caner F Demir, MD study chair
Firat University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Reiki and Self-Acupressure in people with Multiple Sclerosis, run by Firat University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Furkan Bilek, PhD (+905442772249, fzt.furkanbilek@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Multiple Sclerosis Quality of Life (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.